生命科学资讯

Sanofi ousts Paul Hudson after ‘bumpy ride’, poaches Merck KGaA CEO to lead the French pharma

European VCs join forces to boost flagging biotech investment in the region

Revolutionizing Industrial Analysis with Niton Handheld XRF Technology - AZoM

Lonza Group (OTCMKTS:LZAGY) Stock Rating Upgraded by Royal Bank Of Canada - MarketBeat

5 Insightful Analyst Questions From Illumina's Q4 Earnings Call - Finviz

European VCs form coalition to get more support for biotech investing

Atria Investments Inc Decreases Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

UK-Backed PharosAI Cancer Data Project Using Xenium Might Change The Case For Investing In 10x Genomics (TXG) - Yahoo Finance

Why Illumina (ILMN) Is Down 12.9% After 2026 Outlook And SomaLogic Deal Close - And What's Next - simplywall.st

RBC upgrades Lonza Group AG (LZAGY) to Outperform Feb 2026 - Meyka

Sanofi's Paul Hudson out, with Belén Garijo to step in as new CEO

Illumina Director Makes Bold Insider Move With Fresh Stock Purchase - TipRanks

Hinge Health is looking to build AI tools for mental health support

Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus

Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net

UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing

Takeda downsizes Boston footprint amid consolidation effort

Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat

Thermo Fisher Scientific (NYSE:TMO) EVP Gianluca Pettiti Sells 400 Shares - MarketBeat

Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat